Target intelligence / Profile preview

Bacterial rhamnosyltransferase

Molecular classification
Enzyme, Glycosyltransferase
01

Overview

Bacterial rhamnosyltransferase is an enzyme (glycosyltransferase) responsible for transferring L-rhamnose from nucleotide sugar donors (primarily dTDP-L-rhamnose) to acceptor molecules, thereby incorporating rhamnose into bacterial glycans, such as O-antigen polysaccharides and key cell wall linkers.[2][3][4][6] This function is critical for the structural integrity of the bacterial envelope, virulence, and in some species (e.g., Mycobacterium tuberculosis), essential for viability. There are several rhamnosyltransferases in bacteria, with the best characterized including WbbL (involved in O-antigen and mycobacterial cell wall synthesis) and EarP (responsible for post-translational rhamnosylation of elongation factor P, regulating translation and pathogenicity in Pseudomonas aeruginosa).[1][2][4] These enzymes are absent in mammalian cells and represent promising antibiotic or antivirulence targets, as their inhibition can disrupt key bacterial survival structures without directly affecting mammalian pathways.[2][3][6]

Other names
rhamnosyltransferasebacterial RTL-rhamnosyltransferaseWbbL (in Mycobacterium and E. coli)EarP (in Pseudomonas aeruginosa)
02

Mechanism of action

Inhibition of rhamnose transfer to glycoconjugates blocks biosynthesis or modification of bacterial cell envelope components, impairing cell wall integrity and virulence[2][3]

03

Biological functions

Cell envelope biosynthesisGlycan assemblyStructural integrity of bacterial cell wallVirulence factor modification
04

Disease associations

InfectionAntibiotic resistanceBacterial virulence
05

Safety considerations

Target specificity is important due to the absence of rhamnosyltransferases in mammals, but off-target effects or effects on commensal bacteria could be concerns[2]
06

Interacting drugs

6-deoxysugar transition state analogs (experimental inhibitors)

Beyond the preview

Go deeper on Bacterial rhamnosyltransferase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial rhamnosyltransferase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call